{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T05:02:19Z","timestamp":1761541339997,"version":"3.41.0"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vascular Pharmacology"],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1016\/j.vph.2017.03.001","type":"journal-article","created":{"date-parts":[[2017,3,14]],"date-time":"2017-03-14T03:47:50Z","timestamp":1489463270000},"page":"36-41","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Impact of type 2 diabetes on vascular reactivity to cGMP generators in human internal thoracic arteries"],"prefix":"10.1016","volume":"91","author":[{"given":"Masashi","family":"Tawa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeshi","family":"Kinoshita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tohru","family":"Asai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoaki","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeshi","family":"Imamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomio","family":"Okamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vph.2017.03.001_bb0005","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.jphs.2015.09.002","article-title":"Vascular nitric oxide: Beyond eNOS","volume":"129","author":"Zhao","year":"2015","journal-title":"J. Pharmacol. Sci."},{"key":"10.1016\/j.vph.2017.03.001_bb0010","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.vph.2006.08.002","article-title":"Nitric oxide and the endothelium: history and impact on cardiovascular disease","volume":"45","author":"Yetik-Anacak","year":"2006","journal-title":"Vasc. Pharmacol."},{"key":"10.1016\/j.vph.2017.03.001_bb0015","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1038\/nrd2038","article-title":"NO-independent stimulators and activators of soluble guanylate cyclase: discovery and therapeutic potential","volume":"5","author":"Evgenov","year":"2006","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.vph.2017.03.001_bb0020","doi-asserted-by":"crossref","first-page":"2552","DOI":"10.1172\/JCI28371","article-title":"Targeting the heme-oxidized nitric oxide receptor for selective vasodilatation of diseased blood vessels","volume":"116","author":"Stasch","year":"2006","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.vph.2017.03.001_bb0025","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1159\/000371491","article-title":"Effects of peroxynitrite on relaxation through the NO\/sGC\/cGMP pathway in isolated rat iliac arteries","volume":"51","author":"Tawa","year":"2014","journal-title":"J. Vasc. Res."},{"key":"10.1016\/j.vph.2017.03.001_bb0030","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1097\/FJC.0000000000000173","article-title":"Different influences of extracellular and intracellular superoxide on relaxation through the NO\/sGC\/cGMP pathway in isolated rat iliac arteries","volume":"65","author":"Tawa","year":"2015","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"10.1016\/j.vph.2017.03.001_bb0035","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.3109\/10715762.2015.1089987","article-title":"Effect of hydrogen peroxide on soluble guanylyl cyclase redox state in isolated rat iliac arteries","volume":"49","author":"Tawa","year":"2015","journal-title":"Free Radic. Res."},{"key":"10.1016\/j.vph.2017.03.001_bb0040","doi-asserted-by":"crossref","DOI":"10.1002\/prp2.261","article-title":"Soluble guanylate cyclase redox state under oxidative stress conditions in isolated monkey coronary arteries","volume":"4","author":"Tawa","year":"2016","journal-title":"Pharmacol. Res. Perspect."},{"key":"10.1016\/j.vph.2017.03.001_bb0045","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1124\/jpet.113.211029","article-title":"Soluble guanylyl cyclase (sGC) degradation and impairment of nitric oxide-mediated responses in urethra from obese mice: reversal by the sGC activator BAY 60-2770","volume":"349","author":"Alexandre","year":"2014","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.vph.2017.03.001_bb0050","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1016\/j.jacc.2015.02.052","article-title":"Long-term prognosis in patients with type 1 and 2 diabetes mellitus after coronary artery bypass grafting","volume":"65","author":"Holzmann","year":"2015","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.vph.2017.03.001_bb0055","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1152\/physrev.00045.2011","article-title":"Mechanisms of diabetic complications","volume":"93","author":"Forbes","year":"2013","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.vph.2017.03.001_bb0060","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1042\/CS20150093","article-title":"Are reactive oxygen species still the basis for diabetic complications?","volume":"129","author":"Di Marco","year":"2015","journal-title":"Clin. Sci. (Lond.)"},{"key":"10.1016\/j.vph.2017.03.001_bb0065","doi-asserted-by":"crossref","first-page":"2640","DOI":"10.2337\/diabetes.53.10.2640","article-title":"Nitric oxide-sensitive soluble guanylyl cyclase activity is preserved in internal mammary artery of type 2 diabetic patients","volume":"53","author":"Witte","year":"2004","journal-title":"Diabetes"},{"key":"10.1016\/j.vph.2017.03.001_bb0070","doi-asserted-by":"crossref","first-page":"H297","DOI":"10.1152\/ajpheart.00079.2015","article-title":"Reduced vascular responses to soluble guanylyl cyclase but increased sensitivity to sildenafil in female rats with type 2 diabetes","volume":"309","author":"Goulopoulou","year":"2015","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.vph.2017.03.001_bb0075","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.jtcvs.2016.09.037","article-title":"Endothelial dysfunction of internal thoracic artery graft in patients with chronic kidney disease","volume":"153","author":"Kinoshita","year":"2017","journal-title":"J. Thorac. Cardiovasc. Surg."},{"key":"10.1016\/j.vph.2017.03.001_bb0080","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1016\/j.jvs.2010.10.093","article-title":"Preservation of human artery function following prolonged cold storage with a new solution","volume":"53","author":"Garbe","year":"2011","journal-title":"J. Vasc. Surg."},{"key":"10.1016\/j.vph.2017.03.001_bb0085","first-page":"71","article-title":"Nitric oxide-independent activation of soluble guanylate cyclase by BAY 60-2770 in experimental liver fibrosis","volume":"58","author":"Knorr","year":"2008","journal-title":"Arzneimittelforschung"},{"key":"10.1016\/j.vph.2017.03.001_bb0090","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0026-895X(25)09113-8","article-title":"Characterization of 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one as a heme-site inhibitor of nitric oxide-sensitive guanylyl cyclase","volume":"50","author":"Schrammel","year":"1996","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.vph.2017.03.001_bb0095","first-page":"433","article-title":"Immunohistochemical and functional characterization of nitric oxide signaling pathway in isolated aorta from Crotalus durissus terrificus","volume":"155","author":"M\u00f3nica","year":"2012","journal-title":"Comp. Biochem. Physiol. C: Toxicol. Pharmacol."},{"key":"10.1016\/j.vph.2017.03.001_bb0100","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1164\/rccm.200707-1121OC","article-title":"Inhaled agonists of soluble guanylate cyclase induce selective pulmonary vasodilation","volume":"176","author":"Evgenov","year":"2007","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.vph.2017.03.001_bb0105","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1124\/mol.105.018747","article-title":"Biochemistry and pharmacology of novel anthranilic acid derivatives activating heme-oxidized soluble guanylyl cyclase","volume":"69","author":"Schindler","year":"2006","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.vph.2017.03.001_bb0110","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/0024-3205(95)00251-Z","article-title":"Effects of non-insulin dependent diabetes mellitus on the reactivity of human internal mammary artery and human saphenous vein","volume":"57","author":"Karasu","year":"1995","journal-title":"Life Sci."},{"key":"10.1016\/j.vph.2017.03.001_bb0115","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/S1010-7940(01)00778-3","article-title":"Vasoreactivity of arterial grafts in the patient with diabetes mellitus: investigations on internal thoracic artery and radial artery conduits","volume":"20","author":"Wendler","year":"2001","journal-title":"Eur. J. Cardiothorac. Surg."},{"key":"10.1016\/j.vph.2017.03.001_bb0120","doi-asserted-by":"crossref","first-page":"199","DOI":"10.4161\/oxim.3.3.11757","article-title":"Role of gender, smoking profile, hypertension, and diabetes on saphenous vein and internal mammary artery endothelial relaxation in patients with coronary artery bypass grafting","volume":"3","author":"Muir","year":"2010","journal-title":"Oxidative Med. Cell. Longev."},{"key":"10.1016\/j.vph.2017.03.001_bb0125","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1001\/jama.1981.03320190039024","article-title":"The internal mammary artery graft. Its longevity after coronary bypass","volume":"246","author":"Tector","year":"1981","journal-title":"JAMA"},{"key":"10.1016\/j.vph.2017.03.001_bb0130","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1161\/01.CIR.99.1.53","article-title":"Superoxide production, risk factors, and endothelium-dependent relaxations in human internal mammary arteries","volume":"99","author":"Huraux","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.vph.2017.03.001_bb0135","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.cardiores.2006.06.022","article-title":"Internal mammary artery smooth muscle cells resist migration and possess high antioxidant capacity","volume":"72","author":"Mahadevan","year":"2006","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.vph.2017.03.001_bb0140","doi-asserted-by":"crossref","first-page":"2814","DOI":"10.2337\/diabetes.52.11.2814","article-title":"Influence of type 2 diabetes on functional and structural properties of coronary artery bypass conduits","volume":"52","author":"Lorusso","year":"2003","journal-title":"Diabetes"},{"key":"10.1016\/j.vph.2017.03.001_bb0145","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1111\/j.1472-8206.2009.00707.x","article-title":"Human internal thoracic arteries from diabetic patients are resistant to endothelial dysfunction","volume":"23","author":"Grapow","year":"2009","journal-title":"Fundam. Clin. Pharmacol."},{"key":"10.1016\/j.vph.2017.03.001_bb0150","doi-asserted-by":"crossref","first-page":"2415","DOI":"10.2337\/diabetes.54.8.2415","article-title":"Compromised arterial function in human type 2 diabetic patients","volume":"54","author":"Okon","year":"2005","journal-title":"Diabetes"},{"issue":"Suppl. 1","key":"10.1016\/j.vph.2017.03.001_bb0155","doi-asserted-by":"crossref","first-page":"A93","DOI":"10.1186\/2050-6511-16-S1-A93","article-title":"Influence of smoking on vascular reactivity to cGMP generators in human internal thoracic arteries","volume":"16","author":"Tawa","year":"2015","journal-title":"BMC Pharmacol. Toxicol."},{"key":"10.1016\/j.vph.2017.03.001_bb0160","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/S0008-6363(97)00081-3","article-title":"Dyslipidemia and endothelium-dependent relaxation in internal mammary arteries used for coronary bypass surgery","volume":"34","author":"Voors","year":"1997","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.vph.2017.03.001_bb0165","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1097\/00005344-200501000-00002","article-title":"The relationship between risk factors and testosterone-induced relaxations in human internal mammary artery","volume":"45","author":"Yildiz","year":"2005","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"10.1016\/j.vph.2017.03.001_bb0170","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/S1010-7940(98)00193-6","article-title":"Increased tissue endothelin-1-like immunoreactivity in the internal mammary artery of patients with diabetes or hypercholesterolemia modulates the graft flow in the peri-operative period","volume":"14","author":"G\u00f6bel","year":"1998","journal-title":"Eur. J. Cardiothorac. Surg."},{"key":"10.1016\/j.vph.2017.03.001_bb0175","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/S0022-5223(19)34805-6","article-title":"Overcoming perioperative spasm of the internal mammary artery: which is the best vasodilator?","volume":"104","author":"Cooper","year":"1992","journal-title":"J. Thorac. Cardiovasc. Surg."},{"key":"10.1016\/j.vph.2017.03.001_bb0180","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1510\/icvts.2005.111559","article-title":"What is the optimal vasodilator for preventing spasm in the left internal mammary artery during coronary arterial bypass grafting?","volume":"4","author":"Sivalingam","year":"2005","journal-title":"Interact. Cardiovasc. Thorac. Surg."},{"key":"10.1016\/j.vph.2017.03.001_bb0185","first-page":"L318","article-title":"Cinaciguat, a soluble guanylate cyclase activator, causes potent and sustained pulmonary vasodilation in the ovine fetus","volume":"297","author":"Chester","year":"2009","journal-title":"Am. J. Phys. Lung Cell. Mol. Phys."}],"container-title":["Vascular Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1537189116303159?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1537189116303159?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,16]],"date-time":"2025-06-16T19:52:43Z","timestamp":1750103563000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1537189116303159"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4]]},"references-count":37,"alternative-id":["S1537189116303159"],"URL":"https:\/\/doi.org\/10.1016\/j.vph.2017.03.001","relation":{},"ISSN":["1537-1891"],"issn-type":[{"type":"print","value":"1537-1891"}],"subject":[],"published":{"date-parts":[[2017,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of type 2 diabetes on vascular reactivity to cGMP generators in human internal thoracic arteries","name":"articletitle","label":"Article Title"},{"value":"Vascular Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vph.2017.03.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}